NCT01112852View on ClinicalTrials.gov

EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal Bleeding

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Esophageal VaricesBleeding
Interventions
DRUG

pantoloc 40 mg

pantoloc iv. infusion per day

DRUG

somatostatin or terlipressin

Somatostatin 6mg in 500 cc 5% dextrose, 250μg slow bolus IV infusion followed by 250μg per hour (6mg/ 24 hours) or Terlipressin 2mg bolus was instituted on enrollment followed by 1mg per 6 hours for 5 days. The use of either somatostatin or glypressin was at the discretion of doctors in charge.

All Listed Sponsors
lead

National Science and Technology Council, Taiwan

OTHER_GOV

NCT01112852 - EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal Bleeding | Biotech Hunter | Biotech Hunter